VYNE Therapeutics Inc.VYNENASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+39.0%
5Y CAGR-40.6%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+39.0%/yr
Annual compound
5Y CAGR
-40.6%/yr
Recent acceleration
Percentile
P90
Near historical high
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 31.83% |
| 2024 | -49.15% |
| 2023 | 14.69% |
| 2022 | 11.86% |
| 2021 | -115.41% |
| 2020 | 431.24% |
| 2019 | -39.80% |
| 2018 | -84.28% |
| 2017 | -106.48% |
| 2016 | -211.02% |